𝐅𝐃𝐀 𝐂𝐥𝐞𝐚𝐫𝐬 𝐋𝐮𝐦𝐢𝐓𝐡𝐞𝐫𝐚’𝐬 𝐕𝐚𝐥𝐞𝐝𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐃𝐫𝐲 𝐀𝐌𝐃...
𝐅𝐃𝐀 𝐂𝐥𝐞𝐚𝐫𝐬 𝐎𝐜𝐮𝐌𝐞𝐭 𝐁𝐞𝐚𝐜𝐨𝐧 𝐟𝐨𝐫 𝐍𝐨𝐧𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐑𝐞𝐭𝐢𝐧𝐚𝐥 𝐈𝐦𝐚𝐠𝐢𝐧𝐠
👏 OcuSciences has received FDA clearance for the OcuMet Beacon, a noninvasive imaging device that assesses retinal health without dyes, injections, or direct eye contact. Using autofluorescence (AF) and infrared (IR) signals, the Beacon offers a fast, patient-friendly alternative for detecting retinal disease.
👨⚕️ Backed by peer-reviewed studies and set to be featured at ARVO 2025, the OcuMet Beacon is now ready for clinical use across the U.S.—marking a major step forward in early, comfortable retinal diagnostics.
